RVT-3101

Roche pays $7.1B to Roivant for rights to Telavant’s IBD candidate
BioSpace
Mon, 10/23/23 - 10:35 am
Roche
M&A
Televant
Roivant
RVT-3101
IBD
ulcerative colitis
Crohn’s disease
Why Did Pfizer Offload This Potential Mega-Blockbuster Drug?
Motley Fool
Mon, 04/24/23 - 10:18 am
Pfizer
Roivant
IBD
RVT-3101
Fresh from Pfizer deal, Roivant posts 'best-in-class' ulcerative colitis data on rival to Prometheus prospect
Fierce Biotech
Wed, 01/4/23 - 05:22 pm
Roivant Sciences
ulcerative colitis
clinical trials
RVT-3101
Pfizer hands another asset to Roivant
EP Vantage
Fri, 12/2/22 - 10:56 am
Pfizer
Roivant
RVT-3101
PF-06480605
Prometheus Biosciences